Representative Transactional Experience

革新的な技術

• Represented Advanced Micro Devices, Inc., a NASDAQ-listed semiconductor company, in the cash/stock acquisition of ATI Technologies, Inc., a TSX and NASDAQ-listed graphics semiconductor company, and in the acquisition of Nod.ai, an open-source AI software company.*
• Represented City National Bank with respect to multiple fintech acquisitions and joint venture transactions.*
• Represented Cliosoft, Inc., an EDA company, in its sale to Keysight Technologies, Inc.*
• Represented Cognizant Technology Services Corporation, a Fortune 200 tech services company, with respect to multiple acquisitions.*
• Represented Contactual, Inc., a cloud-based telemarketing company, in the cash sale of the company to 8X8, Inc.*
• Represented Digital Air Strike, a private digital marketing company, in a merger with ResponseLogix, Inc.*
• Represented Eximius Design, LLC, a semiconductor design company, in its sale to Wipro.*
• Represented Genstar Capital in the simultaneous acquisitions of a public company and a private company in the health care technology services industries.*
• Represented Honeywell International, Inc., an integrated operating company serving a broad range of industries and geographies around the world, in the acquisition of Compressor Controls Corporation.*
• Represented Hutchison Whampoa Limited, a Chinese telecommunications company, in the cash acquisition of the mediator assets of Luxxon Corporation.*
• Represented IMImobile plc, an AIM-listed company, in the acquisition of 3Cinteractive Corp., a U.S. technology company.*
• Represented Indie Semiconductor, Inc., a NASDAQ-listed semiconductor company, in an acquisition transaction.*
• Represented KKR and Silver Lake in the US$2.7bn LBO acquisition of the semi-conductor products group of Agilent Technologies Inc. to create Avago Technologies Limited.*
• Represented Koninklijke Philips Electronics N.V. in the acquisition of control of two public technology companies.*
• Represented McAfee, Inc., a NASDAQ-listed computer securities solutions company, in the acquisition of a private company.*
• Represented Micrel, Inc., a semiconductor company, in a proxy fight with a hedge fund activist.*
• Represented Microsoft Corporation, a software company, in a joint venture transaction*
• Represented Terayon Communications Systems, Inc., a NASDAQ-listed digital video equipment developer, in the cash sale of the company to Motorola, Inc.*
• Represented Tessera Technologies, Inc., a semiconductor packaging company, in connection with its initial public offering.*
• Represented TrueSpan, Inc., a fabless semiconductor company, in the sale to SiRF Technologies, Inc.*
• Represented VantagePoint Venture Partners, a private equity fund, in the cash acquisition of the worldwide semiconductor assets of the thermal division of ASML, Inc.*
• Represented Verisity Ltd., a NASDAQ-listed EDA company, in the acquisition of a private company, and the subsequent sale of Verisity to Cadence Design Systems, Inc.*
• Represented Xilinx, Inc., a designer and developer of programmable devices and technologies, with respect to multiple acquisitions and corporate venture transactions.*
• Represented Yahoo, Inc. in the acquisition of a Middle Eastern company.*

ヘルスケア・ライフサイエンス

• Represented Aclara Biosciences, Inc., a Nasdaq-listed biotech focused on novel assay solutions for drug discovery and development, in a US$200m stock/CVR merger of equals with Virologics, Inc.*
• Represented Alliance HealthCare Services, Inc., a NYSE-listed medical imaging and radiation therapy company in several private acquisitions and joint ventures, and sale of control transaction.*
• Represented Aviron, a Nasdaq-listed biotech that developed FluMist^TM, in general company representation, registered public offerings of convertible notes and common stock, and the US$1.6bn sale of the company to MedImmune, Inc.*
• Represented Boston Scientific Corporation with respect to several corporate venture financings.*
• Represented Genstar Capital, a private equity fund, in the simultaneous acquisitions of a Nasdaq-listed company and a private company in the healthcare technology services industries.*
• Represented Intuitive Surgical, Inc., a Nasdaq-listed company that developed and commercialized robotic surgical devices, in the acquisition of its Korean distributor.*
• Represented Investor group in the purchase of senior subordinated notes and contingent value rights issued by affiliates of Iterum Therapeutics plc, a Nasdaq-listed pharmaceutical company dedicated to developing and commercializing sulopenem.*
• Represented KKR, a private equity fund, in the sale of a controlling interest in Alliance Imaging, Inc. to Oaktree Capital.*
• Represented Koninklijke Philips Electronics N.V. in the acquisition of control of two Nasdaq-listed medical device companies.*
• Represented Kyphon Inc., a Nasdaq-listed medical device company focused on treatment and restoration of spinal anatomy using minimally invasive technology, in several acquisitions and investments, and in the simultaneous US$4bn sale of the company to Medtronic, Inc. and FTC-mandated divestiture.*
• Represented Molina Healthcare, Inc. with respect to various strategic matters.*
• Represented New Leaf Venture Partners, a venture capital fund, with respect to numerous financing transactions involving private offerings and PIPE transactions.*
• Represented Novartis in an investment in a private company, including an option to acquire the company.*
• Represented Nuvelo, Inc., a Nasdaq-listed gene sequencing company, in general company representation, a registered public offering and several PIPE transactions, and a merger of equals with Variagenics, Inc.*
• Represented QLT Inc., a Canadian Nasdaq-listed biotech focused on macular degeneration, in the US$850m cash/stock acquisition of Atrix Laboratories, Inc.*
• Represented Scios, Inc., a Nasdaq-listed biotech focused on novel treatments for cardiovascular and inflammatory diseases, in the US$2.4bn cash sale of the company to Johnson & Johnson.*
• Represented Veeva Systems Inc., a Nasdaq-listed provider of cloud solutions for the life sciences industry, in the cash acquisition of Zinc Ahead, a U.K. company and leading provider of content management solutions for life sciences companies, for approximately US$130m.*
• Represented Verona Pharma plc, an AIM-listed company, in a securities offering into the U.S.*

*フォリー入社前に取り扱った案件